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Abdominal Aortic Aneurysm
Lederle FA, Freischlag JA, Kyriakides TC, and the OVER Veterans Affairs
Cooperative Study Group. N Engl J Med 2012;367:1988-97.
Conclusion: Endovascular and open repair of abdominal aortic aneu-
rysm (AAA) have similar long-term survival. In those aged <70 years,
survival tends to be better with endovascular repair, whereas in those
aged >70 years, survival appears improved with open repair.
Summary: With the exception of colectomy, aneurysm repair results
in more perioperative deaths than any other general or vascular surgical
procedure, w1250 perioperative deaths per year (Ghaferi AA et al, N
Engl J Med 2009;1361-8-75). Randomized trials have demonstrated
decreased perioperative mortality in patients undergoing endovascular
AAA repair. This survival advantage in the United Kingdom EVAR 1 trial
and the Dutch DREAM trial was lost #2 years due to excess late deaths
in the endovascular repair groups (The United Kingdom EVAR Trial Inves-
tigators, N Engl J Med 2010;362:1863-71; De Bruin JL et al, N Engl J
Med 2010;362:1881-9). In the Veterans Affair Cooperative Study of
Open vs Endovascular Repair (OVER), excess late deaths in the endovascu-
lar groups were not noted at 2 years (Lederle FA et al, JAMA
2009;302:1535-42). The authors of this study present the longer-term
results of the OVER trial. In the trial, 881 patients with asymptomatic
AAAs who were candidates for open or endovascular repair were random-
ized to endovascular repair (n ¼ 444) or open repair (n ¼ 437). Follow-
up is for up to 9 years (mean, 5.2 years). Forty-two Veteran’s Affairs medical
centers participated in the trial, and all patients were aged$49 years at entry
into the trial. More than 95% of patients underwent the assigned repair. The
primary outcome was all-cause mortality, and 146 deaths occurred in each
group (hazard risk [HR] with endovascular repair vs open repair, 0.97;
95% conﬁdence interval [CI], 0.77-1.22; P ¼ .81). The previously reported
reduction in perioperative mortality with endovascular repair was sustained
at 2 years (HR, 0.63; 95% CI, 0.40-0.98; P ¼ .04) and at 3 years (HR, 0.72;
95% CI, 0.51-1.00; P ¼ .05) but not thereafter. In the endovascular repair
group there were 10 aneurysm-related deaths (2.3%) vs 16 in the open
repair group (3.7%; P ¼ .22). Six aneurysm ruptures were conﬁrmed in
the endovascular repair group vs none in the open repair group (P ¼
.03). A signiﬁcant interaction was observed between age and type of treat-
ment (P ¼ .006). Survival was increased among patients aged <70 years in
the endovascular repair group but tended to be better among those aged
>70 years in the open repair group. The two groups did not differ signiﬁ-
cantly with respect to number of secondary therapeutic procedures, number
of hospitalizations after repair, quality of life, or erectile dysfunction.
Comment: Perhaps the most surprising ﬁnding in this study was
that endovascular repair appears to result in better outcomes among
younger patients and in worse outcomes among older patients. The
reasons for this are unclear, but perhaps older patients are less able to
withstand accumulated effects of late graft-based procedures than younger
patients? EVAR remains an acceptable form of management of AAA.
However, as the authors point out, it is somewhat disappointing that
EVAR “does not yet offer a long-term advantage over open repair, partic-
ularly among older patients, for whom such an advantage was originally
expected.”Trends in Antihypertensive Medication Use and Blood Pressure
Control Among United States Adults With Hypertension: The
National Health and Nutrition Examination Survey, 2001-2010
Gu Q, Burt VL, Dillon CF, et al. Circulation 2012;126:2105-14.
Conclusion: The last 10 years has seen a signiﬁcant increase in antihy-
pertension medication use and blood pressure control in the United States
adult population.
Summary: It is well appreciated that reductions in blood pressure
reduce cardiovascular morbidity and mortality and can slow rates of progres-
sion of renal disease. Most patients who are treated with blood pressure
medications for control of hypertension will require two or more hyperten-
sive drugs (Cushman WC et al, J Clin Hypertens [Greenwich] 2002;4:393-
404). The National Health and Nutrition Examination Survey’s
(NHANES) data have for >40 years been used to track progress in prevent-
ing, treating, and controlling hypertension in the United States (Burt VL et
al, Hypertension 1995;26:60-9). In this study, the authors examined recent
trends in antihypertensive medications use and their effect on blood pressure
control in United States adults with hypertension. This analysis included
9320 hypertensive people aged $18 years from the NHANES survey
2001 to 2010. The prevalence of antihypertensive medication use increased
from 63.5% in 2001 to 2002 to 77.3% in 2009 to 2010 (P for trend < .01).
There was a large increase in the use of multiple antihypertensive agents
(from 36.8% to 47.7%; P trend < .01). Use of thiazide diuretics, b-blockers,angiotensin-converting enzyme inhibitors, and angiotensin receptor
blockers increased by 23%, 57%, 31%, and 100%, respectively. In comparison
with monotherapy, single-pill combinations and multiple-pill combinations
were associated with 55% and 26% increased likelihoods of blood pressure
control, respectively. By the 2009 to 2010 time period, 47% of all hyperten-
sive people and 60% of treated hypertensive people had blood pressure
control. Higher treated, but uncontrolled hypertension rates, persisted
among older Americans, non-Hispanic blacks, diabetic people, and those
with chronic kidney disease. Mexican Americans with hypertension were still
less likely to take antihypertensive medications than non-Hispanic whites
with hypertension.
Comment: The NHANES surveys provide important insight into the
effectiveness of primary prevention efforts for cardiovascular disease. The
current survey identiﬁes progress in control of hypertension in the United
States population and identiﬁed patient groups that remain challenges to
achieve compliance with use of antihypertensive medications. To maximize
the public health and clinical beneﬁts of antihypertensive therapy, targeted
efforts to patient groups currently lagging in antihypertensive control will
be necessary.Duration of Resuscitation Efforts and Survival After In-Hospital
Cardiac Arrest: An Observational Study
Goldberger ZD, Chan PS, Berg R, et al. Lancet 2012;380:1473-81.
Conclusion: Efforts to systematically increase duration of resuscita-
tion for in-hospital patients with cardiac arrest could improve survival in
this high-risk population.
Summary: Of every 1000 hospital admissions, one to ﬁve patients in
developed countries will have a cardiac arrest. Of these patients, <20%
survive to discharge (Merchant RM et al, Crit Care Med 2011;39:
2401-6). Little evidence is available to guide clinicians about resuscitation
efforts after cardiac arrest. There is, in fact, little evidence about variation
in lengths of resuscitation efforts after cardiac arrests and their relationship
with potential survival. The authors sought to determine whether there
was an association between the length of the resuscitation effort and
patient survival after in-hospital cardiac arrest. The authors postulated
duration of resuscitation in nonsurvivors would vary between hospitals
and that there would be a higher likelihood of return of spontaneous
circulation and survival to discharge in hospitals where duration of resus-
citation was longer. They identiﬁed 64,339 patients at 435 United States
hospitals between 2000 and 2008 with cardiac arrest. Patients were
derived from the “Get With the Guidelines-Resuscitation” registry. For
each hospital, the median resuscitation before stopping resuscitation efforts
in nonsurvivors was calculated and used as the measure of the hospital’s
overall tendency for longer resuscitation attempts. Multilevel regression
models were used to assess association between length of resuscitation
attempts and risk-adjusted survival. Primary end points were median
survival and return of spontaneous circulation during cardiac arrest and
survival to hospital discharge.
Of the 64,339 patients with cardiac arrest, 31,198 (48.5%) achieved
spontaneous return of circulation and 9912 (15.4%) survived to discharge.
For patients achieving return of spontaneous circulation, median (interquar-
tile range) duration of resuscitation was 12 minutes (6-21 minutes)
compared with 20 minutes (14-30 minutes) for nonsurvivors. Compared
with patients at hospitals in the quartile with the shortest median resuscita-
tion attempts in nonsurvivors (16 [15-17] minutes), those patients at hospi-
tals in the quartile with the longest attempts (25 [25-28] minutes) had
a higher likelihood of return of spontaneous circulation (adjusted risk ratio,
1.12; 95% conﬁdence interval; 1.06-1.18; P < .0001) and survival to
discharge (adjusted risk ratio, 1.12; 95% conﬁdence interval, 1.02-1.23;
P ¼ .021).
Comment: The main points here are that substantial variations exist
between hospitals and duration of resuscitation attempts in patients who
do not survive an in-hospital cardiac arrest and that longer attempts of resus-
citation appear to be associated with a greater likelihood of survival to
discharge. Return of spontaneous circulation and survival to discharge was
less likely if the initial rhythm was pulseless electrical activity or asystole
than when the rhythm was ventricular tachycardia or ﬁbrillation. The
optimum duration of resuscitation attempts could not be deﬁned from
the data but, the data do suggest that efforts to “systematically increase
the duration of resuscitation efforts could improve survival in this high
risk population.”The Role Extracellular Signal-Related Kinase During Abdominal
Aortic Aneurysm Formation
Ghosh A, DiMusto PD, Ehrlichman LK, et al. J Am Coll Surg
2012;215:668-80.
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cellular signal-related kinase (ERK) pathway is an important modulator of
metalloproteinases (MMPs) during abdominal aortic aneurysm (AAA)
formation.
Summary: The mechanism of AAA formation is clearly multifactorial.
However, matrix-degrading metalloproteinases (MMPs), especially
MMP2 and MMP9, appear to be important players in AAA formation.
The MAPK signaling pathway regulates MMPs. There are four basic
MAPK signaling pathways (Murphy LO, et al, Trends Bicochem Sci
2006;31:268-75). Some MAPK signaling pathways have been better
studied than others. For instance, it appears phospho-c-Jun N-terminal
kinase (JNK) is important for activation of MMP9 and therefore potentially
important in AAA formation (Yoshimura K et al, Nat Med 2005;
11:1330-8). ERK modulates MMPs and recruits neutrophils, with resulting
release of cytokines at sites of inﬂammation. Such inﬂammation has been has
been associated with AAA formation. The authors hypothesized phosphor-
ylation of ERK may be an important event in MMP activation and, there-
fore, in AAA formation. The authors used a mouse model of AAA.
C57BL/6 male mice underwent elastase or heat-inactivated elastase aortic
perfusion (n ¼ 9 per group). Smooth muscle cells from the mice were trans-
fected with ERK-1 and 2 siRNA, with and without elastase treatment.
Mouse and human aortic tissue were analyzed by Western blots, zymo-
grams, and immunohistochemistry. Statistical analysis was done with Graph-
Pad and Image J software. Western blot and immunohistochemistry
documented increased phosphomitogen activated protean kinase kinase-
1/2 (pERK-12; 153%; P ¼ .270 by Western blot) and pERK (171%; P ¼
.004 by Western blot) in elastase-perfused aortas. Male ERK-1/ mice
underwent elastase perfusion, and aortic diameter was determined at day
14. ERK-1/ mice failed to develop AAA. Histologic analysis depicted
intact collagen and elastin ﬁbers in the aortas of these mice. Zymography
of aortas of elastase-treated ERK-1/ mice showed lower levels of pro-
MMP2 (P < .005) and active MMP2 (P < .0001), as well as pro-MMP9
(P ¼ .037) compared with c57BL/6 mice. Transfection of ERK-1 and
ERK-2 by short interfering RNA transfection reduced formation of pro-
MMP2 and active MMP2 (P < .01) in both aortic smooth muscle cells
treated with elastase in vitro (P < .01). Human AAA tissue had elevated
levels of pMEK-1/2 (150%; P ¼ .014) and pERK (159%; P ¼ .013)
compared with controlled tissues.
Comment: Targeting the underline biochemical mechanisms of AAA
formation is receiving increasing attention. There are extensive data on the
role of MMPs and AAA formation but little actual data on potential regu-
lators of MMPs. The data here suggest that targeting ERK pathways insuch a way as to inhibit expression or phosphorylation of ERK isoforms is
another potential method to possibly prevent AAA formation in at-risk
patients.Stroke After Carotid Stenting and Endarterectomy in the Carotid
Revascularization Endarterectomy Versus Stenting Trial (CREST)
Hill MD, Brooks W, Mackey A, and the CREST Investigators. Circulation
2012;126:3054-3061.
Conclusion: After carotid intervention in the CREST study, stroke,
particularly severe stroke, was uncommon but was associated with signiﬁ-
cant morbidity and independently associated with a nearly threefold increase
in future death.
Summary: Multiple studies now document stroke is a more frequent
complication of carotid stenting than carotid endarterectomy. In the CREST
trial, strokes were more common after stenting than after endarterectomy,
but myocardial infarctions were more common after endarterectomy. Stroke
had a greater impact than myocardial infarction on quality of life, based on
assessment of the Short Form-36 physical and mental subscales. In this
report, the authors document details regarding strokes occurring in the
CREST trial with respect to stroke type, severity, and other characteristics.
In the CREST trial, stroke was adjudicated by a panel of board-certiﬁed
vascular neurologists, with a secondary central review of brain imaging
studies. Stroke type, laterality, timing, and outcome were reported. Peripro-
cedural stroke occurred among 81 of the 2502 patients randomized in
CREST and among 69 of the 2272 in the present analysis. Of these strokes,
56 (81%,) were minor, 62 (90%) were ischemic, and 65 (94%) were in the
anterior circulation and 51 (88%) were ipsilateral to the treated artery. Seven
hemorrhages occurred at 3 to 21 days after the procedure, and ﬁve were
fatal. Major stroke occurred in 13 of 2272 patients (0.6%). The 4-year
mortality after stoke was 21.1% compared with 11.6% for those without
stroke. Adjusted risk of death at 4 years was higher after periprocedural
stroke (hazard ratio, 2.78; 95% conﬁdence interval, 1.63-4.76).
Comment: The authors previously reported that myocardial infarc-
tion, including biomarker-only myocardial infarction, was associated with
an increased risk of long-term death in the CREST patients. Now, they
also report that strokes, even though most are minor, are also associated
with an increased risk of long-term death in the CREST patients. It is still
unknown whether these periprocedural events in themselves increase the
risk of long-term mortality or are merely markers of more advanced or
aggressive generalized atherosclerotic disease.
